<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05069532</url>
  </required_header>
  <id_info>
    <org_study_id>AATHAD</org_study_id>
    <nct_id>NCT05069532</nct_id>
  </id_info>
  <brief_title>COVID-19 Infection in Hemodialysis Patients</brief_title>
  <official_title>Incidence of COVID-19 Infection in Hemodialysis Patients and Predictors of Disease Complications and Mortality in Assiut University Hospital Hemodialysis Unit: A Cross-Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dialysis patients have a higher risk of infectious complications including complications from&#xD;
      the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes COVID-19. There&#xD;
      have been several reports describing the effect of CO¬VID-19 in the dialysis population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A report of hospitalized COVID-19 patients from Wuhan, China, showed that hemodialysis&#xD;
      patients had worse outcomes compared to controls without kidney failure. In addition, the&#xD;
      hemodialysis COVID-19 patients developed serious complications such as shock, acute&#xD;
      respiratory distress syndrome (ARDS), arrhythmias, and acute cardiac injury at a higher rate.&#xD;
      In a population of hospitalized dialysis patients in New York City, there was a 31% mortality&#xD;
      rate and 75% of those who required mechanical ventilation died.&#xD;
&#xD;
      These complications are due to some of their underlying comorbidities and difficulties of&#xD;
      keeping adequate social distancing as recommended by CDC guidelines.&#xD;
&#xD;
      We aim to identify all hemodialysis patients who will be admitted from October 1, 2021 to&#xD;
      Septemper 30, 2022. Patients who tested positive for COVID-19 by a polymerase chain reaction&#xD;
      (PCR) or highly suspected (CORAD 4-5) according to radiological finding, will be selected and&#xD;
      followed until discharge from hospital to determine who will develop complications and who&#xD;
      will need ventilatory support. Also, the rate of death will be monitored. Therefore, the&#xD;
      current study is aiming to better understand the hemodialysis patients' characteristics&#xD;
      profile that makes them susceptible for complications and death.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of COVID-19 infection in hemodialysis patients.</measure>
    <time_frame>1 year</time_frame>
    <description>radiological and laboratory findings on MSCT chest &amp; PCR respectively.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19 Infection in Hemodialysis Patients</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MSCT chest</intervention_name>
    <description>CORAD 4-5 MSCT chest</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PCR</intervention_name>
    <description>PCR positive for COVID-19</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All hemodialysis patients who defined as patient receiving maintenance dialysis prior to&#xD;
        admission and diagnosed with COVID-19 infection either highly suspicious radiological&#xD;
        findings (CORAD 4-5) or proved by PCR for COVID-19.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All hemodialysis patients who defined as patient receiving maintenance dialysis prior&#xD;
             to admission and diagnosed with COVID-19 infection either highly suspicious&#xD;
             radiological findings (CORAD 4-5) or proved by PCR for COVID-19.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. ALL Patients diagnosed COVID-19 other than hemodialysis patients.&#xD;
&#xD;
          2. Hemodialysis patients with chest infection other than COVID-19.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmad Bahieldeen Ahmad, MD</last_name>
    <phone>01009820300</phone>
    <email>Ahmed-bahei@med.aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashraf Anwar Elshazly, MD</last_name>
    <phone>01069176881</phone>
  </overall_contact_backup>
  <reference>
    <citation>Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, Gharavi AG, Mohan S, Husain SA. Presentation and Outcomes of Patients with ESKD and COVID-19. J Am Soc Nephrol. 2020 Jul;31(7):1409-1415. doi: 10.1681/ASN.2020040470. Epub 2020 May 28.</citation>
    <PMID>32467113</PMID>
  </reference>
  <reference>
    <citation>Tortonese S, Scriabine I, Anjou L, Loens C, Michon A, Benabdelhak M, Ouali S, Morin G, Laifi M, Dobosziewicz H, Guillet M, Dekeyser M, Luong Nguyen LB, Grünenwald A, Dang J, Desbuissons G, Becquemont L, Snanoudj R, Legendre C, Hebibi H, Lefèvre E, Beaudreuil S, Zaidan M; AP-HP/Universities/Inserm COVID-19 research collaboration. COVID-19 in Patients on Maintenance Dialysis in the Paris Region. Kidney Int Rep. 2020 Sep;5(9):1535-1544. doi: 10.1016/j.ekir.2020.07.016. Epub 2020 Jul 18.</citation>
    <PMID>32838082</PMID>
  </reference>
  <reference>
    <citation>Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, Huang B, Fu S, Tan Y, Sun J, Li X. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1139-1145. doi: 10.2215/CJN.04160320. Epub 2020 May 22.</citation>
    <PMID>32444393</PMID>
  </reference>
  <reference>
    <citation>Rombolà G, Heidempergher M, Pedrini L, Farina M, Aucella F, Messa P, Brunori G. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol. 2020 Apr;33(2):193-196. doi: 10.1007/s40620-020-00727-y. Erratum in: J Nephrol. 2020 Mar 30;:.</citation>
    <PMID>32207068</PMID>
  </reference>
  <reference>
    <citation>Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, Liu J, Dong JW, Chen WL, Wang XH, Luo D, Shi M, Miao XP, Zhang C. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol. 2020 Jul;31(7):1387-1397. doi: 10.1681/ASN.2020030354. Epub 2020 May 8.</citation>
    <PMID>32385130</PMID>
  </reference>
  <reference>
    <citation>Corbett RW, Blakey S, Nitsch D, Loucaidou M, McLean A, Duncan N, Ashby DR; West London Renal and Transplant Centre. Epidemiology of COVID-19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020 Aug;31(8):1815-1823. doi: 10.1681/ASN.2020040534. Epub 2020 Jun 19.</citation>
    <PMID>32561681</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 1, 2021</study_first_submitted>
  <study_first_submitted_qc>October 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Aboelfatouh Tantawy</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

